BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 122 filers reported holding BRIDGEBIO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,969,000 | +13.0% | 499,889 | +3.2% | 0.01% | 0.0% |
| Q2 2022 | $4,399,000 | -20.0% | 484,477 | -10.6% | 0.01% | +25.0% |
| Q1 2022 | $5,500,000 | -32.7% | 541,891 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $8,169,000 | -62.6% | 489,721 | +5.1% | 0.00% | -63.6% |
| Q3 2021 | $21,835,000 | -14.7% | 465,876 | +11.0% | 0.01% | -8.3% |
| Q2 2021 | $25,597,000 | +32.9% | 419,892 | +34.3% | 0.01% | +9.1% |
| Q1 2021 | $19,259,000 | +128.5% | 312,645 | +163.8% | 0.01% | +120.0% |
| Q4 2020 | $8,429,000 | +271.5% | 118,532 | +96.0% | 0.01% | +150.0% |
| Q3 2020 | $2,269,000 | +1100.5% | 60,469 | +941.0% | 0.00% | – |
| Q2 2020 | $189,000 | +142.3% | 5,809 | +115.1% | 0.00% | – |
| Q1 2020 | $78,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
| Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
| Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
| SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
| HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
| Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
| Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |